Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Subjects:

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Subjects:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Subjects:

Statins resulted in smaller neuronal soma size. by Shuk C. Tsoi (21192243)

“…Within control birds, the BrdU + /Hu+ neuron population was significantly smaller in soma size than the BrdU-/Hu+ older, heterogeneous population (A). …”

Statins induced flatter neuronal somas. by Shuk C. Tsoi (21192243)

Summary of the screened symptoms at baseline (t0) for completers (n = 160). by Anton Kurapov (11346019)

Subjects:

Summary of the program evaluation. by Anton Kurapov (11346019)

Subjects:

Changes in continuous sleep measures from pre (t1) to post (t2) intervention. by Anton Kurapov (11346019)

Subjects:

Overview over the contents of the app program divided by level [28]. by Anton Kurapov (11346019)

Subjects:

Sociodemographic information, participant flow, engagement, and compliance. by Anton Kurapov (11346019)

Subjects:

Changes in mental health symptoms after the sleep intervention (n = 160 completers). by Anton Kurapov (11346019)

Subjects:

‘Sleep2Ukraine’ study design. by Anton Kurapov (11346019)

Subjects:

Density differences between pre- and post-measurements for program completers (N = 160). by Anton Kurapov (11346019)

Subjects:

Correlations between significantly different microbiota and metabolites. by Bhuripit Saraphol (20855573)

Subjects:

A. Western blot showing accumulation of FoxD3 in CR+DBZ-treated crypt extracts from the colons of Dclk1^ΔIEC mice. by Kafayat Yusuf (22104155)

Co-localization of MMP13 with DCLK1 in various models of colitis. by Kafayat Yusuf (22104155)

Summary of meta-analysis results to compare visfatin level before and after NSPT among cases with periodontitis. by Zahra Tajik (20752452)

Subjects:

List of Included studies. by Zahra Tajik (20752452)

Subjects: